Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD
S. Muiser (Groningen, Netherlands), B. Luijk (Utrecht, Netherlands), G. Braunstahl (Rotterdam, Netherlands), I. Heijink (Groningen, Netherlands), H. Reddel (Sydney, Australia), H. Kerstjens (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands)
Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD
Session: Advances in pharmacological treatment of COPD
Session type: Oral Presentation
Number: 5237
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Muiser (Groningen, Netherlands), B. Luijk (Utrecht, Netherlands), G. Braunstahl (Rotterdam, Netherlands), I. Heijink (Groningen, Netherlands), H. Reddel (Sydney, Australia), H. Kerstjens (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands). Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD. 5237
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: